The relative functional availability of brain noradrenaline and dopamine storage pools.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D004347:Drug Interactions; D005260:Female; D008734:Methoxyhydroxyphenylglycol / Q000378:metabolism; D008781:Methyltyrosines / Q000494:pharmacology; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors
D000317:Adrenergic alpha-Antagonists; D008781:Methyltyrosines; D008734:Methoxyhydroxyphenylglycol; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine; D009638:Norepinephrine